Philanthropic & Academic

NEWS & EVENTS

Tellgen Showcasing at Medica 2022 with Innovative In Vitro Diagnostics Solutions with Great Echos

From November 14th to 17th, the four-day German MEDICA medical equipment exhibition ended successfully. As the largest and most authoritative medical equipment exhibition, this exhibition attracted about 5,000 exhibitors from various countries, with more than 100,000 visitors worldwide. In this exhibition, there were a lot of visitors at the booth of Tellgen. Not only did …

READ MORE
Tellgen Diagnosis Co., Ltd. is accreditated by the China National Accreditation Service of Conformity Assessment

We are happy to announce that Tellgen Diagnosis Co., Ltd. is accreditated by the China National Accreditation Service of Conformity Assessment with Laboratory Accreditation Certificate in October. This remarkable milestone demonstrates Tellgen’s international-standard laboratory quality and globally recognized laboratory management professionalism. China National Accreditation Service for Conformity Assessment (CNAS) is an institution approved by the …

READ MORE

The Protagonist In IVD

Tellgen Corporation is the leading company in the IVD industry, which went public in 2017 with a stock code of 300642. Tellgen was established in 2003 and focused on the needs of patients, doctors, and institutions. Tellgen specializes in chemiluminescence immunoassays, multiplexed bead flow fluorescence immunoassays, mass spectrometry, molecular diagnostics, and clinical chemistry.

MORE ABOUT US
Innovation & Devotion

Focusing On The Needs of Doctors And Patients

Our Mission

Deeper Understanding of Life. We at Tellgen Corporation always focus on the needs of doctors, patients, and institutions. We believe in the power of innovation and devotion.

READ MORE
Our History

Tellgen Corporation was established in 2003 at the Medicine Valley in Shanghai, also known as the Silicon Valley of China, which is the first to develop reagents based on Luminex Platforms.

READ MORE
Our Milestones

Went public in 2017 in Shenzhen and grew to 800 employees. Patented multiple products like Colon9 and LungMe using DNA methylation technology that changed the game of tumor detection.

READ MORE
Our Leaders

Scientists & Philanthropists

Our Friends

Partnerships

Our Partners

Innovation

4